Onnen I
Br J Pharmacol. 1984 Sep;83(1):7-14. doi: 10.1111/j.1476-5381.1984.tb10113.x.
Rat vas deferens preparations became desensitized to the alpha 1-adrenoceptor antagonist thymoxamine: after 6 h in vitro, the t 1/2 value (time to attain half the occupancy of receptors occupied at equilibrium) of the response to this drug was 1.50 fold greater in control strips (strips exposed to thymoxamine at 6 h) than in test strips (strips exposed to thymoxamine at 1 h). The rate of action of the alpha 1-adrenoceptor antagonist AR-C239 on the rat anococcygeus preparation was correlated with the rate of action of atropine. There was also a significant correlation between the t 1/2 ratios (1.37 and 1.30 for AR-C239 and atropine respectively) observed in the control muscles at 6 h. The in vitro slowing is thus due to some change in the longitudinal muscle and not to a change in the receptors. The in vitro slowing occurred when either phenylephrine or methoxamine was the alpha 1-adrenoceptor agonist used. The most likely mechanism of desensitization is a non-specific slowing of the access of drugs to receptors.
大鼠输精管制剂对α1 -肾上腺素能受体拮抗剂噻吗心安产生脱敏:在体外培养6小时后,对照条带(6小时时暴露于噻吗心安的条带)对该药物反应的t1/2值(达到平衡时占据受体一半占有率的时间)比测试条带(1小时时暴露于噻吗心安的条带)大1.50倍。α1 -肾上腺素能受体拮抗剂AR - C239对大鼠肛尾肌制剂的作用速率与阿托品的作用速率相关。在6小时时对照肌肉中观察到的t1/2比值(AR - C239和阿托品分别为1.37和1.30)之间也存在显著相关性。因此,体外减慢是由于纵肌的某些变化,而非受体的变化。当使用去氧肾上腺素或甲氧明作为α1 -肾上腺素能受体激动剂时,体外减慢都会发生。最可能的脱敏机制是药物与受体结合的非特异性减慢。